home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

West Pharmaceutical Services, Inc. Common Stock (NY:WST)

280.83 +1.80 (+0.65%)

Official Closing Price Updated: 7:00 PM EST, Jan 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about West Pharmaceutical Services, Inc. Common Stock

< Previous 1 2

...

5 6 7 8 9 10 11 12 13

...

15 16 Next >

What's going on in today's session: S&P500 gap up and gap down stocks ↗

February 13, 2025

Thursday's session is showcasing interesting market movements in the S&P500 index, with notable gap up and gap down stocks. Stay updated with the gapping S&P500 stocks in today's session.

Via Chartmill

Thursday's session: gap up and gap down stocks ↗

February 13, 2025

Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Thursday. Let's explore the market movements and identify the stocks with significant gaps.

Via Chartmill

US Stocks Edge Higher; Producer Prices Increase In January ↗

February 13, 2025

Via Benzinga

Which S&P500 stocks are moving before the opening bell on Thursday? ↗

February 13, 2025

Stay updated with the S&P500 stocks that are on the move in today's pre-market session.

Via Chartmill

Earnings Scheduled For February 13, 2025 ↗

February 13, 2025

Via Benzinga

(WST) - Analyzing West Pharmaceutical Servs's Short Interest ↗

January 16, 2025

Via Benzinga

Why NYSE:WST is a Top Pick for Dividend Investors. ↗

January 10, 2025

Is WEST PHARMACEUTICAL SERVICES (NYSE:WST) suited for dividend investing?

Via Chartmill

Thursday's pre-market session: top gainers and losers ↗

February 13, 2025

Before the US market kicks off on Thursday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.

Via Chartmill

West Pharmaceutical Services’s (NYSE:WST) Q4: Beats On Revenue But Stock Drops

February 13, 2025

Healthcare products company West Pharmaceutical Services (NYSE:WST) reported Q4 CY2024 results topping the market’s revenue expectations, with sales up 2.3% year on year to $748.8 million. On the other...

Via StockStory

West Pharmaceutical Services (WST) Q4 Earnings Report Preview: What To Look For

February 12, 2025

Healthcare products company West Pharmaceutical Services (NYSE:WST) will be reporting earnings tomorrow morning. Here’s what to look for.

Via StockStory

10 Best Dividend Stocks Using The Dividend Growth Signal ↗

January 09, 2025

Dividend growth is a powerful signal of a company’s financial health, management’s confidence, and commitment to long-term value creation.

Via Talk Markets

Topics Stocks / Equities

Looking Into West Pharmaceutical Servs's Recent Short Interest ↗

December 20, 2024

Via Benzinga

Exploring NYSE:WST's dividend characteristics. ↗

December 20, 2024

Analyzing WEST PHARMACEUTICAL SERVICES (NYSE:WST)'s Dividend Potential.

Via Chartmill

Why NYSE:WST qualifies as a good dividend investing stock. ↗

November 28, 2024

Uncovering Dividend Opportunities with WEST PHARMACEUTICAL SERVICES (NYSE:WST).

Via Chartmill

WEST PHARMACEUTICAL SERVICES (NYSE:WST) Exhibits Quality Stock Traits. Here's Why. ↗

December 30, 2024

WEST PHARMACEUTICAL SERVICES (NYSE:WST) Exhibits Quality Stock Traits. Here's Why.

Via Chartmill

3 Dividend Aristocrats With Long-Term Growth ↗

December 11, 2024

These 3 Dividend Aristocrats have raised their dividends for over 25 years and have long-term growth potential.

Via Talk Markets

Topics Stocks / Equities

Cameco, Applied Digital, West Pharmaceutical And More On CNBC's 'Final Trades' ↗

November 18, 2024

On CNBC's "Halftime Report Final Trades," Tim Seymour of Seymour Asset Management picked Cameco Corporation.

Via Benzinga

Looking Into West Pharmaceutical Servs's Recent Short Interest ↗

November 08, 2024

Via Benzinga

Peering Into West Pharmaceutical Servs's Recent Short Interest ↗

November 06, 2024

Via Benzinga

Balancing Dividends and Fundamentals: The Case of NYSE:WST. ↗

November 04, 2024

Analyzing WEST PHARMACEUTICAL SERVICES (NYSE:WST)'s Dividend Potential.

Via Chartmill

Earnings Outlook For West Pharmaceutical Servs ↗

October 23, 2024

Via Benzinga

(WST) - Analyzing West Pharmaceutical Servs's Short Interest ↗

October 14, 2024

Via Benzinga

Exploring NYSE:WST's dividend characteristics. ↗

September 16, 2024

Exploring WEST PHARMACEUTICAL SERVICES (NYSE:WST)'s dividend characteristics.

Via Chartmill

Is NYSE:WST a Good Fit for Dividend Investing? ↗

August 21, 2024

Why WEST PHARMACEUTICAL SERVICES (NYSE:WST) qualifies as a good dividend investing stock.

Via Chartmill

West Pharmaceutical's Q3 Performance Shows Rising Demand For Syringes, Company Boosts Annual Forecast And Dividend ↗

October 24, 2024

West Pharmaceutical Services reported Q3 adjusted EPS of $1.85, beating estimates, with $746.9 million in sales. Updated 2024 guidance reflects higher EPS and sales.

Via Benzinga

UPS Posts Upbeat Q3 Results, Joins Tesla, Celestica, Pool, T-Mobile And Other Big Stocks Moving Higher On Thursday ↗

October 24, 2024

Via Benzinga

Build-A-Bear Workshop Posts Upbeat Earnings, Joins Affirm, Nutanix, Cooper Companies, Veeva Systems And Other Big Stocks Moving Higher On Thursday ↗

August 29, 2024

Via Benzinga

Balancing Dividends and Fundamentals: The Case of NYSE:WST. ↗

July 31, 2024

Why the dividend investor may take a look at WEST PHARMACEUTICAL SERVICES (NYSE:WST).

Via Chartmill

S&P 500, Nasdaq 100 Mark Seventh Straight Positive Session, Strongest Week Since October 2023: Friday's Top Movers ↗

August 16, 2024

S&P 500 and Nasdaq 100 indices gain for seventh straight day, marking best weekly performance since October 2023 on positive economic data. SPY and QQQ close with modest daily gains while DIA has best...

Via Benzinga

Topics Stocks

Ford, Stellantis And Dell Are Among Top 12 Large Cap Losers Last Week (July 21-July 27): Are The Others In Your Portfolio? ↗

July 28, 2024

Top 10 worst performers last week: EW (-28.05%), F (-19.12%), STM (-17.60%), TER (-16.25%), MBLY (-14.61%), STLA (-13.07%), VRT (-12.04%), SMCI (-11.68%), WST (-11.37%), DELL (-11.26%), UPS (-10.96%),...

Via Benzinga

< Previous 1 2

...

5 6 7 8 9 10 11 12 13

...

15 16 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com